首页 工具
登录
购物车
Semagacestat

Semagacestat

产品编号 T6125   CAS 425386-60-3
别名: LY450139, 塞美司他

Semagacestat (LY450139) 是一种γ-secretase 抑制剂,抑制β-amyloid(Aβ42),Aβ38和Aβ40,IC50分别为 10.9,12 和 12.1 nM,可用于研究阿尔茨海默病。

TargetMol的所有产品和服务仅用于科学研究,不能被用于人体,我们也不向个人提供产品和服务。
Semagacestat Chemical Structure
Semagacestat, CAS 425386-60-3
规格 价格/CNY 货期 数量
1 mg ¥ 262 现货
2 mg ¥ 369 现货
5 mg ¥ 578 现货
10 mg ¥ 1,080 现货
25 mg ¥ 1,920 现货
50 mg ¥ 3,730 现货
100 mg ¥ 5,450 现货
1 mL * 10 mM (in DMSO) ¥ 463 现货
千万补贴 助力科研
BCA蛋白浓度测定试剂盒限时半价
MG-132限时半价
重组蛋白限时优惠
产品目录号及名称: Semagacestat (T6125)
点击图片重新获取验证码
选择批次  
纯度: 99.11%
纯度: 97.1%
更多批次查询请联系客服
生物活性
化学信息
存储 & 溶解度
参考文献
产品描述 Semagacestat (LY450139) (LY450139) is a γ-secretase blocker for Aβ42/Aβ40/Aβ38 (IC50: 10.9/12.1/12.0 nM) and also inhibits Notch signaling (IC50: 14.1 nM).
靶点活性 γ-secretase (Aβ40):12.1 nM, γ-secretase (Aβ38):12.0 nM, γ-secretase (Aβ42):10.9 nM
体外活性 Semagacestat reduces the secretion of Aβ42, Aβ40 and Aβ38 from H4 human glioma cells stably overexpressing human wild-type APP into the culture medium, with IC50 of 10.9 nM, 12.1 nM and 12.0 nM, respectively, without affecting cell viability. Semagacestat also increases β-CTF in cell lysates with ECmax of 16.0 nM, and the increase can be unexpectedly attenuated at high concentrations. Semagacestat inhibits Notch signaling with IC50 of 14.1 nM, and shows minimal Notch-sparing selectivity with Notch IC50/Aβ42 IC50 only 1.3. [1] Semagacestat causes a concentration-dependent decrease in Aβ40 secreted into the medium with IC50 of 111 nM from murine CTX expressing endogenous murine APP, but murine Aβ42 formation in CTX is roughly 12-fold less than Aβ40 in accordance with data for neurons from wild type mice. [2]
体内活性 Oral administration of Semagacestat (1 mg/kg) to 5.5-month old APP-transgenic Tg2576 mice significantly ameliorates memory deficits on spatial working memory using the Y-maze task, which disappears after 8 days subchronic dosing. LY450139 decreases hippocampal levels of both Aβ42 and Aβ40 at 10 mg/kg (22-23% reduction) and 30 mg/kg (36-41% reduction) and increases β-CTF at 0.3-10 mg/kg in a dose dependent manner with no inhibition on the processing of other γ-secretase substrates, such as Notch, N-cadherin or EphA4, in the brain, but impairs normal cognition in wild-type mice and 3-month-old Tg2576 mice failing to restore cognitive deficits in the Y-maze test. [1]
激酶实验 Cellular APP processing assay and Notch signaling assay: H4 human glioma cells stably overexpressing human wild-type APP695 are treated with Semagacestat at various concentrations for 24 hours. Levels of Aβ42, Aβ40, and Aβ38 in the media are measured using separate ELISA kits. The expression vector of the constitutively active form of Notch (NotchΔE), encoding bases 1-60 and 5193-6657 of the human Notch1 coding region (NM_017617), is constructed into a pcDNA3.1 vector with a sequence modification from mouse to human. Notch signaling activity is evaluated using Cignal RBP-Jk Reporter Assay kit. RBP-Jk protein [CSL/CBF1/Su(H)/Lag1] is a transcription factor activated with Notch intracellular domain produced by γ-secretase. H4 cells are transiently transfected with the human NotchΔE expression vector and the RBP-Jk-responsive luciferase construct using Lipofectamine 2000, and then exposed to various concentrations of Semagacestat for 16 hours. Notch signaling is measured based on luciferase activity in the cell lysate using the Dual-Glo Luciferase Assay System.
细胞实验 Cells are incubated with Semagacestat for 24 hours. For detection of cell viability, the percentage of viable cells is quantified by their capacity to reduce 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) following incubation with 0.5 mg/mL MTT for 60 minutes. For the detection of sAPP species, cells are lysed and analysed by western blotting.(Only for Reference)
别名 LY450139, 塞美司他
分子量 361.44
分子式 C19H27N3O4
CAS No. 425386-60-3

存储

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度

H2O: < 1 mg/mL (insoluble or slightly soluble)

DMSO: 67 mg/mL (185.4 mM)

Ethanol: 39 mg/mL (107.9 mM)

溶液配制表

可选溶剂 浓度 体积 质量 1 mg 5 mg 10 mg 25 mg
DMSO / Ethanol 1 mM 2.7667 mL 13.8336 mL 27.6671 mL 69.1678 mL
5 mM 0.5533 mL 2.7667 mL 5.5334 mL 13.8336 mL
10 mM 0.2767 mL 1.3834 mL 2.7667 mL 6.9168 mL
20 mM 0.1383 mL 0.6917 mL 1.3834 mL 3.4584 mL
50 mM 0.0553 mL 0.2767 mL 0.5533 mL 1.3834 mL
100 mM 0.0277 mL 0.1383 mL 0.2767 mL 0.6917 mL

TargetMol Calculator计算器

摩尔浓度计算器
稀释计算器
配液计算器
分子量计算器
=
X
X
X
=
X
=
/
g/mol

输入分子式,点击计算,可计算出产品的分子量。

TargetMol Library Books参考文献

1. Mitani Y, et al. J Neurosci, 2012, 32(6), 2037-2050. 2. Elvang AB, et al. J Neurochem, 2009, 110(5), 1377-1387.
Itanapraced Amyloid β Peptide (42-1)(human) acetate Ezeprogind disulfate RAGE antagonist peptide acetate Amyloid β-Protein 10-20 acetate β-Amyloid 15-21 acetate Dihydroergocristine mesylate Anatabine

相关化合物库

该产品包含在如下化合物库中:
药物功能重定位化合物库 抗癌药物库 抑制剂库 抗癌临床化合物库 神经退行性疾病化合物库 Wnt/Hedgehog/Notch 通路化合物库 已知活性化合物库 抗前列腺癌化合物库 抗乳腺癌化合物库 干细胞分化化合物库

TargetMol Calculator剂量换算

对于不同动物的给药剂量换算,您也可以参考 更多...

TargetMol Calculator 体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。

第一步:请输入动物实验的基本信息
剂量
mg/kg
每只动物体重
g
给药体积
μL
动物数量
第二步:请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
% Tween 80
% ddH2O
计算 重置

技术支持

您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。

Keywords

Semagacestat 425386-60-3 Neuroscience Proteases/Proteasome Stem Cells Beta Amyloid Gamma-secretase LY-450139 Inhibitor inhibit LY 450139 γ-secretase LY450139 β-amyloid peptide 塞美司他 Notch Gamma secretase Amyloid-β Abeta inhibitor

 

TargetMol Loading
陶术
生物
TargetMol®中国区唯一合作伙伴
点击进入陶术生物官网陶术生物
联系我们
400-820-0310

上海市静安区江场三路238号8楼